Skip to content

CrisisCope: ICBT for Psychological Symptoms Related to Life Crises.

CrisisCope: Internet-based CBT Intervention for Distress Related to Life Crises.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05673382
Enrollment
80
Registered
2023-01-06
Start date
2023-01-19
Completion date
2024-06-24
Last updated
2023-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Symptoms, Depressive Symptoms

Keywords

Life crises, Randomized controlled trial, Internet-based cognitive behavioral therapy (ICBT), Internet intervention, Depression, Anxiety

Brief summary

The aim with this study is to investigate the effects of internet-based cognitive behavioral therapy (ICBT) on psychological symptoms related to one or more life crises. The target group is adults (18 years or older) who have symptoms of depression, anxiety, stress, or other psychological distress related to one or more life crises. The ICBT consists of eight modules during eight weeks with weekly support by a therapist and the treatment group will be compared to a wait-list control condition. Participants will be recruited in Sweden with nationwide recruitment.

Detailed description

The study is a randomized controlled trial about the effects of ICBT aiming to target psychological symptoms related to one or more life crises. Primary outcome measures are depressive symptoms (measured with Beck Depression inventory-II) and anxiety symptoms (measured with Generalized Anxiety Disorder-7). Other outcome measures used will for example be about adaptability, stress symptoms, sleep problems, post traumatic stress symptoms and quality of life. Because the psychological impact of a life crisis can be diverse, between different people and between different kinds of crises, a transdiagnostic individually tailored treatment will be used that has been tested in several previous trials. This treatment has been adopted to target psychological symptoms related to life crises.

Interventions

The intervention (the treatment) within this study is based on cognitive behavioral therapy principles and adapted to target psychological symptoms related to life crises. The 20 modules that the intervention consists of include psycho-educational texts as well as examples and exercises.

Sponsors

Linkoeping University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

After recruitment finished, participants will be randomized to either intervention condition (treatment group) or control condition (wait-list). Participants in the control condition will receive the same treatment once the treatment group has finished the treatment and outcome measures has been collected from both groups.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Experience psychological symptoms related to one or more life crises. * 18 years or older * Adequate ability to speak, read and write Swedish * Having access to the internet and a smartphone, computer or other device

Exclusion criteria

* Severe psychiatric or somatic issues that makes participation harder or impossible * Ongoing addiction * Acute suicidality * Other ongoing psychological treatment * Recent (within the past three months) changes in dose of psychotropic medication or planned change during the treatment weeks

Design outcomes

Primary

MeasureTime frameDescription
Beck Depression Inventory-IIChange between Baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.Measure of depressive symptoms. Range for the total sum is between 0 and 63 with a higher score score indicating a higher level of depressive symptoms. Clinical ranges for minimal, mild, moderate and severe major depressive disorder are considered to be 0-13, 14-19, 20-28, and 29-63 respectively.
Generalized Anxiety Disorder-7Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.Measure of anxiety symptoms and worry. When summing the points of the seven first questions, the scores are interpreted as mild, moderate and severe anxiety symptoms at 5-10, 11-15, and above 15 respectively

Secondary

MeasureTime frameDescription
Perceived Stress Scale-14Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.A questionnaire that aims to measure symptoms of stress. It contains of 14 items that are scored on a range between 0 (never) and 4 (very often). The total score range is between 0-56 and a higher score reflects higher levels of perceived stress.
Insomnia Severity IndexChange between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.Measure of insomnia severity and symptoms of disordered sleep. Norm score ranges include low likelihood of sleep problems (0-7 points), some sleep problems (8-14 points), moderate sleep problems (15-21 points), severe sleep problems (22-28 points).
Alcohol Use Disorder Identification TestChange between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.A ten-item scoring tool to assess alcohol consumption, drinking behaviors, and alcohol-related problems. Scores are ranging from 0-40 with higher scores indicating a higher level of alcohol use.
Impact of Events Scale-RevisedChange between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.Assesses subjective distress caused by traumatic events.Items are rated on a five-point scale from 0 (not at all) to 4 (extremely). Total score range between 0-88, with a higher score indicating more severe distress caused by the traumatic events.
Brief Adjustment Scale-6Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination. Also, every week during the treatment weeks.A measure of general psychological adjustment, consisting of six items. The items are on a seven-point response scale with higher scores indicating lower general psychological adjustment.
InCharge Financial Distress/Financial Well-Being ScaleChange between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.A measure aiming to measure distress related to the individual's economic situation. It consists of eight questions where the respondent gets to answer on a scale from 1 to 10.
Medical Outcome Study Social Support SurveyChange between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.A 12-item questionnaire aiming to measure the individual's perceived social support that is answered on a five-point scale (1-5). Besides the 12 items, the questionnaire also includes a question about how many family members and friends that the individual experience to have, who he/she can talk to. Total score range between 12 to 60.
Posttraumatic Growths Inventory-Short formChange between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.A questionnaire consisting of 10 items, aiming to investigate the individual's experience of positive change in relation to challenging life events. Each item are answered on a six-point scale ranging between 0 to 5, resulting in a total score range between 0-60.
Brunnsviken Brief Quality of Life ScaleChange between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.Measure of quality of life with a total score ranging from 0 to 96 with a higher score indicating higher quality of life. The scores of each of the six primary questions regarding perceived quality of life within an area of life are multiplied with the score of an item measuring the perceived importance of the area in question.
Patient Health Questionnaire-9Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.Measure of depressive symptoms. Possible range for the total sum is 0 to 27 (created by summing up the scores from each item) with a higher score indicating higher levels of depression. Clinical cut-offs for mild, moderate, moderately severe and severe major depressive disorder are considered to be 5, 10, 15 and 20 respectively.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026